Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical

An article discussing the benefits of rejuvenation for your friends and family.

Rejuvenation biotechnologies would bring significant benefits to individuals, but these benefits would indirectly extend to their families and friends too. The ways they can benefit from the rejuvenation of others might be not so obvious, so let’s have a look at them together.

Nearly everyone knows how terrible it is to lose people dear to you. Maybe your grandparents died when you were a child, and that might have been your first encounter with death, at an age when you still couldn’t properly comprehend it. Maybe it happened suddenly, or maybe your grandparents have suffered for long before passing away. Eventually, the moment comes when you start thinking that the same fate awaits your parents, your siblings, your friends. Rejuvenation would spare you seeing your elderly relatives and friends wilt away, suffer and die, because none of that would happen to them. Of course, rejuvenation would spare this pain to your friends and relatives too. Your children and grandchildren would never have to see you become sicker and sicker as you age, and would never—in principle—have to bury you. Today, being 80 means you often have to attend the funeral of a dear friend who passed away. People who have been important parts of your life just keep dying.

Read more

This is one of the first articles I’ve seen specifically on #Judiasm and #transhumaism, with input by rabbis. Naturally the article is cautious, but interesting too.

Transhumanism, an intellectual and cultural movement supporting the use of science and technology to improve human mental and physical characteristics and capacities, a concept once limited to the realm of science-fiction, is now becoming more of a reality than ever before. The once outlier philosophy is quickly becoming mainstream, an accepted part of the social conscience that is the new religion for the anti-religious, including its own Messianic vision.

There are many aspects to the transhumanism philosophy, often abbreviated as H+ or h+, including physical longevity through medical breakthroughs and/or merging mankind with machines. Many transhumanists advocate transferring the sum total of a person’s knowledge and experiences into a computer and recreating the individual as a form of artificial intelligence ( AI ) in order to extend an individual’s life.

In its most extreme form, transhumanism advocates limiting human population. This extreme philosophy is criticized for being eugenicist master-race ideology and infringing on basic reproductive rights.

Continue reading “Synergy Between Torah and Science: How Far is TOO Far?” | >

Rudrapur, Uttrakhand, India — July 02, 2017

Revita Life Sciences, (http://revitalife.co.in) a biotechnology company focused on translational regenerative therapeutic applications, has announced that it is continuing to advance their novel, multi-modality clinical intervention in the state of brain death in humans.

“We have proactively continued to advance our multi-modality protocol, as an extended treatment before extubation, in an attempt to reverse the state of brain death” said Mr.Pranjal Agrawal, CEO Revita Life Sciences. “This treatment approach has yielded some very encouraging initial outcome signs, ranging from minor observations on blood pressure changes with response to painful stimuli, to eye opening and finger movements, with corresponding transient to permanent reversal changes in EEG patterns.”

This first exploratory study, entitled “Non-randomized, Open-labelled, Interventional, Single Group, and Proof of Concept Study with Multi-modality Approach in Cases of Brain Death Due to Traumatic Brain Injury Having Diffuse Axonal Injury” is ongoing at Anupam Hospital, Rudrapur, Uttrakhand. The intervention primarily involves intrathecal administration of minimal manipulated (processed at point of care) autologous stem cells derived from patient’s fat and bone marrow twice a week.

This study was inappropriately removed from the Indian Council of Medical Research (ICMR) database. ICMR has no regulatory oversight on such research in India.

The Central Drugs Standard Control Organization (CDSCO), Drug Controller General of India, had no objection to the program progressing. Regulatory approval as needed for new drugs, is currently not required when research is conducted on the recently deceased, although IRB and family consent is definitely required. CDSCO, the regulator of such studies, clearly states that “no regulatory requirements are needed for any study with minimal manipulated autologous stem cells in brain death subjects”.

Death is defined as the termination of all biological functions that sustain a living organism. Brain death, the complete and irreversible loss of brain function (including involuntary activity necessary to sustain life) as defined in the 1968 report of the Ad Hoc Committee of the Harvard Medical School, is the legal definition of human death in most countries around the world. Either directly through trauma, or indirectly through secondary disease indications, brain death is the final pathological state that over 60 million people globally transfer through each year.

“We are in process of publishing our initial retrospective results, as well ongoing early results, in a peer reviewed journal. These initial findings will prove invaluable to the future evolution of the program, as well as in progressing the development multi-modality regenerative therapeutics for the full range of the severe disorders of consciousness, including coma, PVS, the minimally conscious state, and a range of other degenerative CNS conditions in humans,” said Dr. Himanshu Bansal, Chief Scientific Officer, Revita Life Sciences and Director of Mother Cell.

With the maturation of the tools of medical science in the 21st century, especially cell therapies and regenerative medicines, tissues once considered irretrievable, may finally be able to be revived or rejuvenated. Hence many scientists believe that brain death, as presently defined, may one day be reversed. While the very long term goal is to find a solution for “re-infusing life”, the short term purpose of these types of studies is much less dramatic, which is to confirm if the current definition of brain irreversibility still holds true. There have been many anecdotal reports of brain death reversal across the world over the past decades in the scientific literature. Studies of this nature serve to verify and establish this very fact in a scientific and controlled manner. It will also one day give a fair chance to individuals, who are declared brain dead, especially after trauma.

About Revita Life Sciences

Revita Life Sciences is a biotechnology company focused on the development of stem cell therapies and regenerative medicine interventions that target areas of significant unmet medical need. Revita is led by Dr. Himanshu Bansal MD, who has spent over two decades developing novel MRI based classifications of spinal cord injuries as well as comprehensive treatment protocols with autologous tissues including bone marrow stem cells, Dural nerve grafts, nasal olfactory tissues, and omental transposition.

The June Journal Club video is now available for your viewing pleasure. Dr. Oliver Medvedik talks about telomeres and cellular reprogramming in this latest edition of our new live streamed monthly show.

It has been a busy few months since we launched our Lifespan Heroes campaign on Lifespan.io the aim of which is to help us expand the scale and scope of our activities.

June 27th saw our second monthly Journal Club, this is a regular live broadcast to our Facebook page where we discuss the latest scientific research papers hosted by Dr. Oliver Medvedik at the Cooper Union biotechnology lab.

Continue reading “Journal Club June 2017 Video Available” | >

Gearing up for clinical trials.

Liz discusses how we can overcome the limits on human health and lifespan; elaborating on BioViva’s role as a translational engine to provide access to cutting-edge therapies for those most in need.

http://journey100.org | Journey to 100 is a world-exclusive conference exploring ideas for a new and sustainable approach to lifelong health. The day kick starts a 10-year project that aims to make Guernsey the first community in the world to break through the 100-year life expectancy barrier.

Continue reading “BioViva at Journey to 100” | >

As if anyone needed any excuse to drink more beer, a team of researchers have managed to produce an alcoholic beverage that also contains probiotics. In a novel breakthrough, they claim that the beer could help improve gut health and immunity, though the science is still out on that last one.

There are plenty of dairy-based probiotics, but currently there are no beers that also contain probiotics, mainly because beer contains something known as hop acids, which limit the growth and survival of potential probiotics. This spurred the researchers at the National University of Singapore to see if they could manage it.

They succeeded in developing a sour beer that can support the probiotic strain known as Lactobacillus paracasei L26. This particular probiotic is already found in the human gut, and there is some evidence that it might be able to regulate the immune system.

Read more

Rapid developments in brain-machine interfacing and neuroprosthetics are revolutionizing the way we treat paralyzed people, but the same technologies could eventually be put to more generalized use—a development that’ll turn many of us into veritable cyborgs. Before we get to that point, however, we’ll need to make sure these neural devices are safe, secure, and as hacker-proof as possible.

In anticipation of our cyborg future, researchers from the Wyss Center for Bio and Neuroengineering in Geneva Switzerland have published a new Policy Forum paper in Science titled, “Help, hope, and hype: Ethical dimensions of neuroprosthetics.” The intent of the authors is to raise awareness of this new breed of neurotechnologies, and the various ways they can be abused. Importantly, the researchers come up with some ways to mitigate potential problems before they arise.

Read more

Philadelphia, PA, USA / Moscow, Russia — Bioquark, Inc., (www.bioquark.com) a life sciences company focused on the development of novel bio-products for regeneration, disease reversion, and healthy aging, and Moscow based, Lakmus LLC, a diversified investment company with business interests in pharmacies, restaurants, and real estate, announced a multi-disciplinary research collaboration with the FSBI Zakusov Institute of Pharmacology, Russian Academy of Medical Sciences (http://www.academpharm.ru/), and the Pavlov Institute of Physiology of the Russian Academy of Sciences (http://www.infran.ru/), to jointly study the pharmacotherapeutic longevity enhancement properties of its combinatorial regenerative biologic candidates.

“We are very excited about this continued collaboration with Lakmus,” said Ira S. Pastor, CEO, Bioquark Inc. “The disciplined development of our combinatorial biologic candidates (Bioquantines) for healthy longevity enhancement, represents another important step in our continued evolution as a company focused on a broad range of therapeutic products and services in the regenerative healthcare space.”

Throughout the 20th century, natural products formed the basis for a majority of all pharmaceuticals, biologics, and consumer healthcare products used by patients around the globe, generating trillions of dollars of wealth. However, many scientists believe we have only touched the surface with what the natural world, and its range of organisms, which from a health and wellness perspective are much further advanced than human beings, has to teach us.

The integration of a complex set of newer research disciplines, including interkingdom signaling, semiochemical communication, and evolutionary biology, as well as significant recent activity in the areas of the microbiome, are highlighting a myriad of new ways that non-human bio-products can affect the human genome for positive transitions in health and wellness dynamics.

“Bioquark has spent several years studying the natural ability of many species to turn back biological time in order to maintain health, fitness, and survival, developing a broad understanding of the combinatorial biochemical approaches they use to control nested hierarchies of disease (i.e. gene, cell, tissue, organism, environment),” said Dr. Sergei Paylian, Founder, CSO, and President, Bioquark Inc. “This research initiative is one more step in the path in allowing humans to recapture these capabilities to effectively counter our unfortunate progression into aging, disease and degeneration.”

About Bioquark, Inc.

Bioquark Inc. is focused on the development of natural biologic based products, services, and technologies, with the goal of curing a wide range of diseases, as well as effecting complex regeneration. Bioquark is developing both biological pharmaceutical candidates, as well as products for the global consumer health and wellness market segments.